Has Michael Latshaw, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,748 in general payments to Michael Latshaw, MD across 69 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Latshaw, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Latshaw, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Latshaw, MD

Otolaryngology · Bessemer, ALNPI 1558622191

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.4% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 28.1% of the total. 2025 is the largest year on record at $908, more than ten times the $52 reported in 2019. That places this record below the midpoint for otolaryngology clinicians in AL, where the typical reported total is $1,585.

$1,748in general payments, 2019–2025

Across 69 payments — averaging $25.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron Healthcare Solutions, Inc.$491
GSK$219
Sanofi$215
Inspire Medical Systems, Inc.$180
AbbVie$159
Novo Nordisk$155
plus $329 from 8 others

What the payments were for

Food & beverage$1,65094%
Education$986%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron Healthcare Solutions, Inc.	20	$491
GSK	11	$219
Sanofi	7	$215
Inspire Medical Systems, Inc.	7	$180
AbbVie	3	$159
Novo Nordisk	9	$155
Stryker	1	$126
Optinose US, Inc.	3	$64
Acera Surgical, Inc.	2	$40
Axsome Therapeutics, Inc.	1	$24
Aerin Medical Inc.	2	$24
Integra Lifesciences Corporation	1	$21
Johnson & Johnson	1	$16
Hikma Pharmaceuticals USA	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,748 in reported general payments places this provider in the 50th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama →

Medicare billing

Part B allowed, 2024

$68,868

Medicare patients

239

Services billed

1,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	26	$3,065
Azelastine Hcl	64	$1,931
Ipratropium Bromide	53	$1,283
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	85	$1,030
Methylprednisolone	102	$837
Famotidine	36	$573
Dexamethasone Sodium Phosphate	11	$453
Clindamycin Hcl	33	$322
Fluticasone Propionate	23	$317
Ibuprofen	37	$303
Levocetirizine Dihydrochloride	25	$239
Montelukast Sodium	27	$238
Doxycycline Hyclate	17	$228
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	27	$184
Azithromycin	31	$179

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Bessemer

John DavisHoover$251K
William McFeelyHuntsville$70K
Michael SillersBirmingham$53K
Justin TurnerBirmingham$34K
Bradford WoodworthBirmingham$27K
Patrick OwensBirmingham$26K
Kirk WithrowBirmingham$22K
Do-Yeon ChoBirmingham$19K
William BlytheOpelika$19K
Andrew FusonBirmingham$18K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →